Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies (Nasdaq: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced it will release its fourth quarter and full year 2024 financial results after market close on Monday, February 10, 2025.
The company will host a conference call to discuss these results on Tuesday, February 11, 2025, at 8:30 a.m. ET. Investors can access the webcast through Axcelis' website investor section or register directly as participants. The webcast replay will be available for 30 days after the call.
Axcelis Technologies (Nasdaq: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has announced its participation in the 27th Annual Needham Growth Conference. The event will take place at the Lotte New York Palace Hotel from January 14-17, 2025.
The company will conduct a fireside chat on Tuesday, January 14th at 3:00 p.m. EST and will be available for one-on-one meetings. Investors and interested parties can access a live webcast of the presentation through the Investors' section of Axcelis' website or via the provided webcast link. The presentation recording will remain available for 90 days after the event.
Axcelis Technologies (Nasdaq: ACLS) will showcase its Purion™ and GSD Ovation™ Series of ion implanters at SEMICON Japan 2024, taking place December 11-13 at Tokyo Big Sight. The company will present its comprehensive product lineup, including the Purion Power Series™ for silicon and silicon carbide wafer processing, Purion H™ Series for high current operations, and other specialized implanter solutions. The event will feature a technical presentation on SiC Power Device Manufacturing Ion Implant Technology and a networking reception. Axcelis aims to expand its market share in Japan by providing advanced ion implant technology to local chipmakers.
Axcelis Technologies (Nasdaq: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has announced its participation in two upcoming investor conferences. The company will attend the 2024 Wells Fargo TMT Summit at the Terranea Resort in Rancho Palos Verdes on December 3-4, 2024, where management will conduct one-on-one investor meetings. Additionally, Axcelis will participate in the 13th Annual NYC Summit at Mastro's New York on December 17, 2024, hosting small group meetings. The NYC Summit is invitation-only, restricted to accredited investors and publishing research analysts.
Axcelis Technologies (NASDAQ: ACLS) reported Q3 2024 financial results with revenue of $256.6 million, slightly up from $256.5 million in Q2. Operating profit decreased to $46.9 million from $52.8 million, while net income fell to $48.6 million ($1.49 per diluted share) from $50.9 million ($1.55 per share). Gross margin declined to 42.9% from 43.8%. The company expects Q4 2024 revenues of approximately $245 million with EPS of $1.25. Additionally, Axcelis corrected historical backlog figures, with Q2 2024 backlog revised to $879 million from previously reported $994 million. Q3 2024 backlog stands at $758 million.
Axcelis Technologies (Nasdaq: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced the timing for its third quarter 2024 financial results. The company will release its Q3 2024 results on Wednesday, November 6, 2024, at 4:00 p.m. ET.
Following the release, Axcelis will host a conference call to discuss the results on Thursday, November 7, 2024, at 8:30 a.m. ET. Investors and interested parties can access the call via a webcast through the Investors page of Axcelis' website or by registering as a participant through a provided link. The webcast replay will be available for 30 days after the call.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced its participation in the International Conference on Silicon Carbide and Related Materials (ICSCRM 2024). The event will take place from September 29 to October 4, 2024, at the Raleigh Convention Center in North Carolina. Axcelis' management will be available for one-on-one meetings during the conference.
Dr. Russell Low, President and CEO of Axcelis, expressed excitement about participating in ICSCRM 2024, describing it as one of the most important technology forums in the power market. He highlighted the company's Purion™ Power Series as the technology leader in this market, citing its enabling and highly differentiated features and process control. Dr. Low also emphasized the critical role of ion implant in manufacturing Silicon Carbide devices, a market estimated by Yole to grow at a 25% CAGR from 2023 to 2029.
Axcelis Technologies (NASDAQ: ACLS) announced its Platinum Sponsorship of the International Conference on Ion Implantation Technology 2024 (IIT 2024) in Toyama, Japan. The event, scheduled for September 23-26, focuses on challenges in implant/doping and annealing processes, device applications, equipment, metrology, and modeling. Axcelis will host an exhibit and present nine topics, including performance of aluminum sputtering sources, energetic metals characterization, radiation mitigation, and innovations in wide bandgap materials.
CEO Russell Low emphasized the importance of the Japanese market for Axcelis, noting recent openings of new Service Centers in Japan. The company aims to grow its global market share by providing innovative implant technology and support solutions.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the inaugural SEMICON India 2024, showcasing its Purion™ and GSD Ovation™ Series of ion implanters. The event will be held from September 11-13 at the India Expo Mart in Greater Noida, Delhi. Axcelis will exhibit in Booth #H1T11, featuring innovative ion implant solutions that offer significant technology and manufacturing advantages.
The showcase includes the Purion Power Series™ for thin silicon, TAIKO, and SiC wafer processing; the Purion H Series for high current implants; the Purion XE Series for high energy implants; and the GSD Ovation™ for cost-effective batch platform capability. CEO Russell Low highlighted the importance of the Indian semiconductor market, projected to reach over $55 billion by 2026, driven by smartphones, automotive components, and computing sectors.
Axcelis Technologies (NASDAQ: ACLS), a key player in ion implantation solutions for the semiconductor industry, announced its participation in several upcoming investor conferences.
August 22nd: 5th Annual Needham Virtual Semiconductor & SemiCap 1x1 Conference.
August 27th: Jefferies Semiconductor, IT Hardware, Communications Software and Infrastructure Summit at the Four Seasons Hotel, Chicago, IL.
August 28th: Evercore ISI 2024 Semiconductor, IT Hardware & Networking Conference at the Omni Chicago.
September 4th: Benchmark 2024 Tech/Media/Telecom Conference at the New York Athletic Club.
September 12th: B. Riley Securities Consumer & TMT Conference at the Sofitel, New York.
Management will be available for one-on-ones and small group meetings at these events.